The importance of tumor proliferation markers in assessing lesions of the palatine tonsil

Rom J Morphol Embryol. 2011;52(3 Suppl):1033-9.

Abstract

Oropharyngeal cancer, and especially squamous cell carcinoma, is one of the most common cancers worldwide, and its incidence is increasing, with the palatine tonsil being one of the main locations. The etiopathogenic factors, together with its location as well as the available immunohistochemical methods, make this type of cancer an accessible one in terms of diagnosis. However, it is usually diagnosed in late stages. Therefore, we tried to elucidate the causes of treatment failures and development of local recurrence. For this, we reassessed the proliferative pattern of tonsil lesions using the anti-p53, anti-PCNA and anti-Ki67 antibodies on 73 tonsil fragments collected after curative surgery on adults aged between 28 and 86 years. Following the reevaluation of the histopathological examination using markers for cell proliferation, the diagnosis was modified in 16 cases, representing about 22% of the cases take into study. By using immunohistochemical markers in the histopathological examination the diagnosis is improved, leading to a more appropriate therapeutical approach.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / metabolism*
  • Carcinoma, Squamous Cell / metabolism
  • Carcinoma, Squamous Cell / pathology
  • Cell Differentiation
  • Cell Proliferation
  • Epithelium / metabolism
  • Epithelium / pathology
  • Humans
  • Immunohistochemistry
  • Palatine Tonsil / metabolism*
  • Palatine Tonsil / pathology*
  • Proliferating Cell Nuclear Antigen / metabolism
  • Stromal Cells / pathology
  • Tonsillar Neoplasms / metabolism*
  • Tonsillar Neoplasms / pathology*
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Biomarkers, Tumor
  • Proliferating Cell Nuclear Antigen
  • Tumor Suppressor Protein p53